You can enrol in up to 20 courses during temporary access. You’ve reached this limit and can’t enrol in any more right now.
Once you have full access, you’ll be able to enrol without limit.
A multi-disciplinary group of healthcare professionals has developed a practical guide to aid the early identification and management of gastrointestinal (GI) symptoms in children who require oral nutritional supplements.
GI symptoms are common in childhood and can have a significant physical and emotional impact on children,1 as well as causing worry and anxiety for their families.2 Data has shown that 7.3% of children requiring oral nutritional supplements (ONS) experience a GI symptom in the two weeks prior to receiving a prescription for ONS,3 which may then impact on the success of the nutritional intervention.
The consensus guide ‘A practical guide to identifying and managing GI symptoms in children who require oral nutritional supplements’, supported by Abbott, has been developed by a multi-disciplinary group with a specialist interest in paediatric gastrointestinal issues. It has been designed to support members of the multidisciplinary team (MDT) identify, assess and manage GI symptoms in children. It brings all the information together in a concise format that is easy to use on a day-to-day basis, including recommendations for screening, assessment and monitoring procedures.
Click here to download the guide (PDF, 136KB).
The group members were Dr Susan Hill, Consultant Paediatric Gastroenterologist, Great Ormond Street Hospital, London; Jenny Livingstone, Specialist Paediatric Gastroenterology, Hepatology and Nutrition Dietitian, The Royal Hospital for Sick Children, Edinburgh; Elizabeth Loring, Community Paediatric Dietitian, Central and North West London NHS Foundation Trust; Dr Nick Mann, Consultant Paediatrician, The Berkshire Independent Hospital, Reading; Sara Patience, Registered Health Visitor and Registered Nutritionist, Surrey; Rita Shergill-Bonner, Principal Dietitian, Great Ormond Street Hospital, London; and Dr Richard Stevens, GP, Oxford and Committee Member Primary Care Society for Gastroenterology.
1. Data on file. Abbott Laboratories Ltd., 2012 (PaediaSure Peptide case studies)
2. Hommel KA et al. J Clin Psychol Med Settings 2010;17(2):159–166.
3. Data on file. Abbott Laboratories Ltd., 2013 (Cegedim Data).
Recyclability


Abbott is in the business of helping people live longer and better at all ages and stages of life through good health. Sustainability is an essential part of this, and an essential part of our mission.

![]()
Paediatric patients represent a particularly vulnerable group with specific nutritional requirements, but feeding difficulties are unfortunately a common occurrence. Up to 75% of critically ill children and 90% of chronically ill children may be malnourished or have suboptimal nutrition, which in turn can lead to impaired growth and development.

Fibre is an essential nutrient for human health that has short and long-term benefits.1 Despite this, most children, including those with disease-related malnutrition receiving nutrition support, fall short of daily recommended intakes. Evidence to support restriction of fibre in specific disease states is lacking, however, healthcare professionals (HCPs) often advise low fibre diets.
UK-N/A-2200386 (V2) | October 2023
SESSION TIMEOUT
Please log in to continue
Thanks for registering. To begin, please log in to your ProConnect account. After you log in, you’ll have temporary access to all resources and education while we verify your details.
Added to Bag
ENSURE PLUS
1 x 220 ml
Flavor: Apple
1,5 kcal / ml
Nutrition Information
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
footnotes
Product details not available.
You have {liteUserDaysLeft} business days of temporary access.
Based on your email address {email} your account has not yet been approved. We’re validating your credentials. You won’t be able to order samples until your account is approved and activated. Please check your email for more details. For help, contact us at abbott.proconnect_access@nhs.net.
UK--2500192 | September 2025
You have {liteUserDaysLeft} business days of temporary access.
Based on your email address {email} your credentials are validated but not yet activated. To gain full access, including the ability to order samples, click the activation link we sent to your inbox. For help, contact us at abbott.proconnect_access@nhs.net.
UK--2500192 | September 2025
Register to continue reading this article
UK-N/A-2400058(v9) | September 2025
You are about to exit for another Abbott country or region specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimised for your specific screen size.
Do you wish to continue and exit this website?
UK-N/A-2200465 | July 2022
This website is for UK HCPs and UK Patients only. If you are outside of the UK please visit our global website Abbott.com
If you choose "I am a patient/carer”, you will be entering a website intended for patients and carers which has information on Abbott products. Products on this website are to be used under medical supervision. If you have questions about the product information discussed on this website, you should consult with your healthcare professional.